Last Update: January 18, 2023, 11:02 IST
In December, the intranasal COVID-19 vaccine was approved by the Union health ministry as a booster dose for those aged 18 years and above. (Twitter @PBNS_India)
Nasal vaccines may be more effective at preventing infection because they target the mucosal lining of the nasal airways, which are the entry points of the coronavirus.
Bharat Biotech’s INCOVACC is a nasal COVID-19 vaccine that will soon be ready for circulation to the public in India as a booster dose. This type of vaccine is unique because it is sprayed directly into the nose, eliminating the need for injections. It is designed to protect the mucosal lining of the nasal airways, where the virus first enters the body, and block infection and transmission of the virus in both the upper and lower respiratory tracts. The vaccine is recommended as the first booster shot and will be given twice with an interval of 28 days to adults over the age of 18 who have completed two doses of Covaxin or Covishield but have not had a booster shot . Side effects are generally mild and may include headache, fever, or runny nose. It is not recommended for individuals who are allergic to any of its components or have had severe allergic reactions in the past. The vaccine is available in hospitals and will be circulated among people from the fourth week of January. You can book your appointment quickly.
how does it work?
Nasal vaccines have the potential to be more effective at preventing infection because they target the mucosal lining of the nasal airways, which is the point of entry for the coronavirus. By protecting these linings, the vaccine may prevent infection and transmission of the virus in both the upper and lower respiratory tract. INCOVACC is recommended as the first booster shot. People will be vaccinated twice at an interval of 28 days.
Who can get the runny nose vaccine?
Adults over the age of 18 who have completed 2 doses of Covaxin or Covishield but have not received a booster shot are eligible to receive the nasal vaccine.
Side Effects of Nasal Vaccines
Nasal vaccines have very few or mild side effects, which may include headache, fever, or runny nose. It is not recommended for people who are allergic to any of its components or have had a severe allergic reaction in the past.
Government of India has approved the vaccination of nasal vaccine in view of increasing cases of COVID. It is available on CoWin and is priced at Rs 800 for private markets and Rs 325 for the Government of India.
read all Latest Lifestyle News Here